Can a simple gas save lives after heart surgery? major trial launches

NCT ID NCT06702553

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This phase 3 trial tests whether giving inhaled nitric oxide during and after heart surgery can lower the risk of death or major complications like kidney failure, stroke, and heart failure. About 3,650 adults having elective heart surgery with a heart-lung machine will receive either nitric oxide or a placebo gas. The goal is to see if this treatment reduces the need for intensive life support within 30 days after surgery.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
inhaled nitric oxide gas
What this could lead to
If it works, this could become a standard treatment to prevent life-threatening complications like kidney failure, stroke, or heart failure after heart surgery.
What could go wrong
Earlier smaller studies showed benefits in lab tests but not in survival or recovery. This large trial aims to confirm if those benefits are real, but it may still fail to improve hard outcomes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ADULT PATIENTS UNDERGOING CARDIOVASCULAR SURGERY WITH CARDIOPULMONARY BYPASS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Cardiology Research Institute, Tomsk National Research Medical Center

    NOT_YET_RECRUITING

    Tomsk, 634012, Russia

  • Massachusetts General Hospital, Department of Anesthesia, Critical Care and Pain Medicine

    NOT_YET_RECRUITING

    Boston, Massachusetts, 02114, United States

  • Xijing Hospital

    RECRUITING

    Xi'an, Shaanxi, 710032, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.